se of aromatherapy for anxiety and stress in the general community due to social isolation caused by the Covid-19 pandemic
- Conditions
- anxiety disordersF06.4
- Registration Number
- RBR-5xp737h
- Lead Sponsor
- niversidade de Franca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Participants must be over 18 years old and less than 60 years old; They must reside in the city for at least 12 months; Present internet access with a valid email address or a valid WhatsApp number. Present a score above 8 on the Depression, Anxiety and Stress Scale anxiety test and above 10 on the general test.
Age within 18 years or above 60 years; Not residing in Franca/SP; Use benzodiazepines in the last 30 days; Use non-selective monoamine reuptake inhibitors (Imipramine, Clomipramine, Amitriptyline, Nortriptyline) , Serotonin Reuptake Inhibitors and ALPHA-2 (alfa2) Antagonists (Nefazodone, Trazodone), Selective Dopamine Reuptake Inhibitors (Bupropion), ALPHA-2 (alfa2) Antagonists (Mirtazapine), Monoamine Oxidase Inhibitors (Tranylcypromine, Moclobemide); Not having high blood pressure. Not being pregnant.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find the anxiolytic potential of the aromatic blend developed for this purpose, from the identification of the DASS21 scale (Depression, Anxiety and Stress Scale), compared to the beginning. We also want to find a difference between the intervention group and the placebo control.
- Secondary Outcome Measures
Name Time Method It is expected to find the potential on sleep quality through the aromatic blend developed for this purpose compared to the beginning. It is also desired to find a difference between the intervention group and placebo control.